LY3478006
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY3478006, covering 2021-12-06 to 2021-12-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY3478006 in Healthy Participants [Phase 1]